The modern landscape of oncology drug development is characterized by profound scientific breakthroughs, yet it remains perpetually bottlenecked by an…
Read More
GSK Expands Oncology Footprint with Chimagen Trispecific T-Cell Engager Deal for Multiple Myeloma
British pharmaceutical giant GSK has significantly deepened its footprint in the oncology sector by securing the global rights to an…
Read More
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Solstice Oncology has successfully closed a landmark $225 million Series A funding round to accelerate the clinical development of its…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
More than a decade ago, the American Society of Clinical Oncology (ASCO) initiated CancerLinQ, a pioneering platform designed with the…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
Over a decade ago, the American Society of Clinical Oncology (ASCO) initiated a groundbreaking endeavor with the launch of CancerLinQ,…
Read More
A Colorful Gecko’s Cancer Susceptibility Offers New Hope for Human Oncology Research
The world of pet reptiles has unveiled a surprising ally in the fight against cancer. A vibrant, naturally occurring mutation…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
In a significant advancement for precision oncology, ConcertAI, a leading AI and real-world data company focused on cancer care, has…
Read More
Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital, and industry converge at Campus Grand Parc.
The recent inauguration of THE HIVE at Campus Grand Parc in Paris marks a significant inflection point for Europe’s oncology…
Read More
Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases
Immunai, a leading artificial intelligence (AI) company specializing in immune system analysis, and Boehringer Ingelheim, a global biopharmaceutical giant, have…
Read More
Novartis and Antares Therapeutics Forge Landmark Oncology Collaboration to Tackle Undruggable Cancer Targets
In a significant move poised to accelerate the development of novel cancer therapies, Novartis has entered into a strategic collaboration…
Read More
